| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CPB1 | CPB2 | ENSOCUP00000002682 | ENSOCUP00000015415 | Carboxypeptidase B1. | Carboxypeptidase B2. | 0.851 |
| CPB1 | CPE | ENSOCUP00000002682 | ENSOCUP00000007068 | Carboxypeptidase B1. | Uncharacterized protein. | 0.597 |
| CPB2 | CPB1 | ENSOCUP00000015415 | ENSOCUP00000002682 | Carboxypeptidase B2. | Carboxypeptidase B1. | 0.851 |
| CPB2 | CPE | ENSOCUP00000015415 | ENSOCUP00000007068 | Carboxypeptidase B2. | Uncharacterized protein. | 0.884 |
| CPE | CPB1 | ENSOCUP00000007068 | ENSOCUP00000002682 | Uncharacterized protein. | Carboxypeptidase B1. | 0.597 |
| CPE | CPB2 | ENSOCUP00000007068 | ENSOCUP00000015415 | Uncharacterized protein. | Carboxypeptidase B2. | 0.884 |
| CPE | INS | ENSOCUP00000007068 | ENSOCUP00000020463 | Uncharacterized protein. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.672 |
| CPE | PAM | ENSOCUP00000007068 | ENSOCUP00000001375 | Uncharacterized protein. | Peptidylglycine alpha-amidating monooxygenase. | 0.656 |
| CPE | PCSK1 | ENSOCUP00000007068 | ENSOCUP00000010457 | Uncharacterized protein. | Proprotein convertase subtilisin/kexin type 1. | 0.745 |
| CPE | PCSK1N | ENSOCUP00000007068 | ENSOCUP00000007790 | Uncharacterized protein. | Proprotein convertase subtilisin/kexin type 1 inhibitor. | 0.588 |
| CPE | PCSK2 | ENSOCUP00000007068 | ENSOCUP00000013658 | Uncharacterized protein. | Proprotein convertase subtilisin/kexin type 2; Belongs to the peptidase S8 family. | 0.781 |
| CPE | PRCP | ENSOCUP00000007068 | ENSOCUP00000044768 | Uncharacterized protein. | Prolylcarboxypeptidase. | 0.606 |
| CPE | SCG2 | ENSOCUP00000007068 | ENSOCUP00000022967 | Uncharacterized protein. | Secretogranin II. | 0.571 |
| CPE | SCG3 | ENSOCUP00000007068 | ENSOCUP00000023678 | Uncharacterized protein. | Secretogranin III. | 0.638 |
| INS | CPE | ENSOCUP00000020463 | ENSOCUP00000007068 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Uncharacterized protein. | 0.672 |
| INS | PAM | ENSOCUP00000020463 | ENSOCUP00000001375 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Peptidylglycine alpha-amidating monooxygenase. | 0.541 |
| INS | PCSK1 | ENSOCUP00000020463 | ENSOCUP00000010457 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Proprotein convertase subtilisin/kexin type 1. | 0.906 |
| INS | PCSK2 | ENSOCUP00000020463 | ENSOCUP00000013658 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Proprotein convertase subtilisin/kexin type 2; Belongs to the peptidase S8 family. | 0.845 |
| INS | SCG2 | ENSOCUP00000020463 | ENSOCUP00000022967 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Secretogranin II. | 0.509 |
| PAM | CPE | ENSOCUP00000001375 | ENSOCUP00000007068 | Peptidylglycine alpha-amidating monooxygenase. | Uncharacterized protein. | 0.656 |
